Skip Navigation


Studies




Email This Page Print This Page Change Font Size
Print This Page for Your Doctor


New Search


1 through 5 of 5            Reset Filters 
Sort By:                       Trial Title    |    Age Range    |    Last Updated  
Title begins with...   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z    

 
Effects of Coenzyme Q10 in Parkinson Disease - Phase III (QE3)
  • Keyword(s): Parkinson disease, PD, Coenzyme Q10, CoQ




  • Location:
    • Phoenix, Arizona


  • Status:
    • Open and enrolling subjects
    • Last Updated Monday, September 21, 2009


  • Age Range
    • 18 and older


  • Summary
    • The purpose of this study is to evaluate the safety and effectiveness of high dosages of Coenzyme Q10 in slowing clinical decline in people who have early Parkinson disease.


  • Primary Sponsor
    • Weill Medical College of Cornell University


  • More Information


 
Read more!
Adding Surgery to Meds May Improve Life With Parkinson's  4/29/2010 12:00:00 AM (CST)


Deep brain stimulation is risky but can be beneficial, researchers say
 
Randomized, Double-Blind, Parallel Group, Placebo Controlled Safety, Tolerability and Efficacy Study of NP002 in Subjects With Idiopathic Parkinson's Disease With Dyskinesias Due to Levodopa Therapy (NP002-09-001)
 
Read more!
A Primer on Parkinson's Disease  2/5/2009 12:00:00 AM (MST)


Some Parkinson's symptoms, such as slowness or stiffness, are so subtle that they may be mistaken for normal signs of aging.
 
Double-blind, Placebo Controlled, Randomized, Multicenter Study to Assess the Safety and Clinical Benefit of Rasagiline as an Add on Therapy to Stable Dose of Dopamine Agonists in the Treatment of Early Parkinson's Disease (TVP-1012/PM103)
 
Read more!
A Primer on Parkinson's Disease  2/5/2009 12:00:00 AM (MST)


Some Parkinson's symptoms, such as slowness or stiffness, are so subtle that they may be mistaken for normal signs of aging.
 
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Trimethobenzamide (Tigan®) in the Control of Nausea and Vomiting During Initiation and Continued Treatment With Subcutaneous Apomorphine (Apokyn®) in Apomorphine-naïve Subjects With Parkinson's Disease Suffering From Acute Intermittent "Off" Episodes, With Phased Withdrawal of Subjects From Tigan® to Placebo (Y-47-52844-003)
  • Keyword(s): Parkinson's disease, Anti-emetic, Nausea, Vomiting




  • Location:
    • Phoenix, Arizona


  • Status:
    • Open and enrolling subjects
    • Last Updated Wednesday, June 23, 2010


  • Age Range
    • 18 and older


  • Summary
    • The purposes of the study are to determine: i. To assess the efficacy of Tigan® (trimethobenzamide) in preventing nausea and vomiting when initiating therapy with Apokyn® (apomorphine); ii. To determine the optimal duration for continuation of Tigan® following initiation of Apokyn® therapy; iii. To assess the safety of Tigan® in combination with Apokyn®; iv. To characterize the pharmacokinetic (PK) profile of apomorphine in subjects treated concomitantly with and without Tigan®


  • Primary Sponsor
    • Ipsen


  • More Information


 
Read more!
A Primer on Parkinson's Disease  2/5/2009 12:00:00 AM (MST)


Some Parkinson's symptoms, such as slowness or stiffness, are so subtle that they may be mistaken for normal signs of aging.
 
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (IPX066-B09-02)
  • Keyword(s): Parkinson's Disease




  • Location:
    • Phoenix, Arizona


  • Status:
    • Completed
    • Last Updated Wednesday, June 23, 2010


  • Age Range
    • 18 and older


  • Summary
    • A randomized, double-blind, active-control, parallel-group 13-week comparison of IPX066 versus regular carbidopa-levodopa (CD-LD). Prior to randomization, subjects on a stable regular LD regimen will enter a 3-week Dose-Adjustment period for regular CD-LD, followed by a 6-week Dose-Conversion period to IPX066.


  • Primary Sponsor
    • IMPAX Laboratories, Inc.


  • More Information


 
Read more!
Adding Surgery to Meds May Improve Life With Parkinson's  4/29/2010 12:00:00 AM (CST)


Deep brain stimulation is risky but can be beneficial, researchers say
Epilepsy

Epilepsy

We are seeking individuals with epilepsy to participate in research studies at St. Joseph's.

Learn more...


Brain Tumors

Brain Tumors

We are seeking individuals with Brain Tumors to participate in research studies at St. Joseph's.

Learn more...

Browse Trials by Area

We have also organized the clinical trial by area. Hover over the highlighted areas on the map to locate trials in your area.

Click the highlighted areas to find trials

Browse Trials by Conditions

We have also organized the clinical trial by Health Conditions. Choose a condition from the drop-down menu to start your search.

Bottom of Navigation